Migdal Insurance & Financial Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$34.54 - $47.25 $459,554 - $628,661	-13,305 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$42.51 - $63.78 $351,005 - $526,631	8,257 Added 163.57%	13,305 $598,000
Q4 2020 Feb 08, 2021	BUY	$45.3 - $60.27 $228,674 - $304,242	5,048 New	5,048 $285,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$518 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$377 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$319 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$288 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account